Astrazeneca (AZN) rejected 78 million British pounds ($96.4 million) of UK government support after the new administration sought to reduce the amount of public support the company was promised by the previous administration to build a vaccine manufacturing facility, according to Financial Times, citing people briefed on the matter.
AstraZeneca said Friday that it was canceling plans to invest 450 million pounds in a vaccine manufacturing facility in Speke, England, which it attributed to the cut in government funding support.
The previous government had offered the pharmaceutical company 90 million pounds, which includes 70 million pounds in grants for the factory and 20 million pounds in research and development support from the UK Health Security Agency, the FT reported.
AstraZeneca did not immediately respond to a request for comment from MT Newswires.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。